COMMUNIQUÉS West-GlobeNewswire

Nabriva Therapeutics to Present at the Needham and Company 18th Annual Healthcare Conference
02/04/2019
DUBLIN, Ireland and KING OF PRUSSIA, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat [...]
Athenex Announces Appointment of John Koh as a New Board Member
02/04/2019
BUFFALO, N.Y., April 02, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Unum Therapeutics to Present at Two Upcoming Investor Conferences
02/04/2019
CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies to treat cancer based on its [...]
Innovate Biopharmaceuticals to Announce First Quarter 2019 Financial Results and to Provide Operational Progress Updates on April 29, 2019
02/04/2019
Innovate plans to provide an operational progress update, including regarding its first phase 3 celiac disease clinical trial Topline NASH preclinical data expected to be released at the Digestive Disease Week (DDW) [...]
Meridian Bioscience Announces Preliminary Second Quarter 2019 Revenue Results; Updates Fiscal 2019 Guidance
02/04/2019
CINCINNATI, April 02, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today provided a business update including preliminary [...]
LHC Group and Geisinger finalize joint venture agreement for home health and hospice services in Pennsylvania
02/04/2019
LAFAYETTE, La. and DANVILLE, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) and Geisinger Home Health and Hospice finalized a previously announced joint venture partnership to enhance home health [...]
MannKind to Present at the H.C. Wainwright Global Life Sciences Conference
02/04/2019
WESTLAKE VILLAGE, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases [...]
The Ensign Group Acquires Arizona Skilled Nursing Facility
02/04/2019
MISSION VIEJO, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]
The Ensign Group Acquires Texas Memory Care Community
02/04/2019
MISSION VIEJO, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]
Evoke Pharma Receives Complete Response Letter and Recommendations to Address Deficiencies from FDA for Gimoti™ NDA
02/04/2019
SOLANA BEACH, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has [...]
Philips presents results from 3-year telehealth program impacting over 100,000 patients across Europe
02/04/2019
April 2, 2019 Advancing Care Coordination & Telehealth Deployment at Scale ( ACT@Scale ) Handbook now available to implement and grow population health management to improve patient care and reduce costs in an aging [...]
Lexington Biosciences Provides Update on Financial Situation
02/04/2019
VANCOUVER, British Columbia, April 02, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announced on February 14, 2019 that it had been unable to secure the [...]
Community Health Network decides for C-RAD’s innovative SIGRT solution
02/04/2019
C-RAD and Community Health Network announced today an agreement to equip three of their cancer centers located in the state of Indiana with C-RAD’s surface tracking solution based on Catalyst and Sentinel 4DCT. [...]
LIDDS announces a novel TLR9 agonist project and plan for Phase I clinical trial
02/04/2019
Clinical data shows that intratumoral delivery of TLR agonists in combination with immune checkpoint inhibitors can effectively treat solid cancers. NanoZolid® technology is very suitable to provide sustained [...]
Curetis Introduces Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance
02/04/2019
Knowledge base of antimicrobial resistance (AMR) markers tailored specifically to Unyvero Applications Developed by Curetis’ subsidiary Ares Genetics and powered by ARESdb Initial focus on Unyvero Pneumonia Applications [...]
Novartis first-in-class Cosentyx® approved in China for psoriasis patients
02/04/2019
China Health Authority NMPA approved Cosentyx ® (secukinumab) for moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy Cosentyx is the first biologic approved in [...]
FDA Approves ASCENIV™, a Novel Intravenous Immune Globulin
02/04/2019
Approved for Use in the Treatment of Primary Humoral Immunodeficiency Disease (“PIDD” or “PI”) in Adults and Adolescents (12 to 17 Years of Age) FDA Approval Triggers Funding up to $27.5M from Existing Credit Facility [...]
MediciNova Announces Results of Subgroup Analysis from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS
02/04/2019
LA JOLLA, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
BriaCell Announces Closing of Upsized & Oversubscribed Non-Brokered Private Placement of $2.97 Million
02/04/2019
BERKELEY, Calif., and VANCOUVER, British Columbia, April 01, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]

Pages